109 related articles for article (PubMed ID: 575123)
21. [Cisplatin and derivatives with radiation therapy: for what clinical use?].
Durdux C
Cancer Radiother; 2004 Nov; 8 Suppl 1():S88-94. PubMed ID: 15679253
[TBL] [Abstract][Full Text] [Related]
22. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells.
Rockwell S; Irvin CG; Nierenburg M
Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554
[TBL] [Abstract][Full Text] [Related]
23. Tumour radiosensitization by nicotinamide: is it the result of an improvement in tumour oxygenation?
Horsman MR; Nordsmark M; Khalil A; Chaplin DJ; Overgaard J
Adv Exp Med Biol; 1994; 345():403-9. PubMed ID: 8079736
[No Abstract] [Full Text] [Related]
24. [Mexamine as a means of increasing the anti-tumor effect of irradiation in animals. 3].
Berezhnoza LI; Rampan IuI; Iarmonenko SP
Radiobiologiia; 1971; 11(5):727-31. PubMed ID: 5149732
[No Abstract] [Full Text] [Related]
25. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons.
Fowler JF; Sheldon PW; Denekamp J; Field SB
Int J Radiat Oncol Biol Phys; 1976; 1(7-8):579-92. PubMed ID: 977399
[No Abstract] [Full Text] [Related]
26. Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents.
Graham CH; Kobayashi H; Stankiewicz KS; Man S; Kapitain SJ; Kerbel RS
J Natl Cancer Inst; 1994 Jul; 86(13):975-82. PubMed ID: 8007019
[TBL] [Abstract][Full Text] [Related]
27. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.
Denekamp J; Harris SR
Radiat Res; 1975 Feb; 61(2):191-203. PubMed ID: 1110975
[No Abstract] [Full Text] [Related]
28. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
[TBL] [Abstract][Full Text] [Related]
29. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.
Horsman MR; Siemann DW; Nordsmark M; Khalil AA; Overgaard J; Chaplin DJ
Adv Exp Med Biol; 1994; 361():635-42. PubMed ID: 7597993
[No Abstract] [Full Text] [Related]
30. Effects of sodium pentobarbital on the radiation response of EMT6 cells in vitro and EMT6 tumors in vivo.
Rockwell S; Loomis R
Radiat Res; 1980 Feb; 81(2):292-302. PubMed ID: 7360886
[No Abstract] [Full Text] [Related]
31. Interactions of radiation, cyclophosphamide and nimorazole in a C3H mammary carcinoma in vivo.
Zachariae C; Overgaard J
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1445-8. PubMed ID: 3759571
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.
Dudek AZ; Zwolak P; Jasinski P; Terai K; Gallus NJ; Ericson ME; Farassati F
Invest New Drugs; 2008 Feb; 26(1):13-24. PubMed ID: 17805485
[TBL] [Abstract][Full Text] [Related]
33. Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.
Iwakawa M; Tofilon PJ; Arundel C; Milas L
Cancer Res; 1989 Apr; 49(7):1640-3. PubMed ID: 2924311
[TBL] [Abstract][Full Text] [Related]
34. Camptothecin dose, schedule, and timing of administration for clinical radiation sensitization.
Rich TA; Kirichenko AV
Ann N Y Acad Sci; 2000; 922():334-9. PubMed ID: 11193916
[No Abstract] [Full Text] [Related]
35. The proteasome inhibitor PS-341 in cancer therapy.
Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J
Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy involving photosensitizing agents.
Kessel D
J Photochem Photobiol B; 1992 Jan; 12(2):203-4. PubMed ID: 1619518
[No Abstract] [Full Text] [Related]
37. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
McNally NJ; Denekamp J; Sheldon P; Flockhart IR; Stewart FA
Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269
[No Abstract] [Full Text] [Related]
38. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. III. Cis-diamminedichloroplatinum.
Twentyman PR; Kallman RF; Brown JM
Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1365-7. PubMed ID: 575121
[No Abstract] [Full Text] [Related]
39. [Studies on the mammary tumor inhibiting effect of cis-dichlorobis(glycylglycinethylester)platinum(II) (author's transl)].
Seidenberger H; Kranzfelder G; Wappes B; Schönenberger H; Beck W; Girnth M
Arch Pharm (Weinheim); 1981 Nov; 314(11):955-67. PubMed ID: 7198899
[No Abstract] [Full Text] [Related]
40. The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
Choi YJ; Heo K; Park HS; Yang KM; Jeong MH
Int J Oncol; 2016 Oct; 49(4):1479-88. PubMed ID: 27498957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
